Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.

Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, Bernasconi E, Gutmann C, Ledergerber B; Swiss HIV Cohort Study Group..

HIV Med. 2012 Feb;13(2):118-26. doi: 10.1111/j.1468-1293.2011.00949.x.

2.

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.

Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, D'Acremont V, Battegay M, Wagels T, Bernasconi E, Kopp C, Furrer H; Swiss HIV Cohort Study..

AIDS. 2003 Oct 17;17(15):2237-44.

PMID:
14523281
3.

Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.

Staehelin C, Keiser O, Calmy A, Weber R, Elzi L, Cavassini M, Schmid P, Bernasconi E, Furrer H; Swiss HIV Cohort Study..

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):79-85. doi: 10.1097/QAI.0b013e318236be70.

PMID:
21937923
4.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635.

PMID:
23100567
5.

Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.

Mohsen AH, Murad S, Easterbrook PJ.

HIV Med. 2005 May;6(3):206-15.

6.
7.

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].

Caro-Murillo AM, Gutiérrez F, Manuel Ramos J, Sobrino P, Miró JM, López-Cortés LF, Tural C, Moreno A, de Los Santos I, Murillas J, Camino X, Salavert M, Rubio R, Moreno S, del Amo J; CoRIS..

Enferm Infecc Microbiol Clin. 2009 Aug-Sep;27(7):380-8. doi: 10.1016/j.eimc.2008.10.007. Spanish.

PMID:
19427080
8.

Loss to follow-up in an international, multicentre observational study.

Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD; EuroSIDA study group..

HIV Med. 2008 May;9(5):261-9. doi: 10.1111/j.1468-1293.2008.00557.x.

9.

Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R; APROCO COPILOTE ANRS CO8 Study Group..

HIV Med. 2007 Apr;8(3):164-70.

10.

Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.

Ndiaye B, Ould-Kaci K, Salleron J, Bataille P, Bonnevie F, Choisy P, Cochonat K, Fontier C, Guerroumi H, Ajana F, Chaud P, Yazdanpanah Y.

Antivir Ther. 2009;14(4):567-75.

PMID:
19578242
11.

[HIV infection in immigrants: clinical and epidemiological differences as compared to the native population in a Health Area in Madrid (2002-2004)].

Jerez AH, García-Cerrada C, Ortega FP, García RR, Gómez RH, González CC, Pérez-Herrero JR.

Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):441-5. Spanish.

PMID:
17692212
12.
13.

Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.

Smith PR, Sarner L, Murphy M, James B, Thomas JM, Skinner CJ, Aitken C.

J Clin Virol. 2003 Jan;26(1):101-7.

PMID:
12589840
14.

Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.

Pérez-Molina JA, López-Vélez R, Navarro M, Pérez-Elías MJ, Moreno S.

J Travel Med. 2009 Jul-Aug;16(4):248-52. doi: 10.1111/j.1708-8305.2009.00308.x.

15.

Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies.

Weisser M, Rudin C, Battegay M, Pfluger D, Kully C, Egger M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 15;17(5):404-10.

PMID:
9562042
16.

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study.

Pérez Molina JA, Rillo MM, Suárez-Lozano I, Casado Osorio JL, Cobo RT, González PR, Clotet EP, Jerez AH, Pedrol PD, Royuela A, Díaz EB, Esteban H, González-García J.

Curr HIV Res. 2010 Oct;8(7):521-30.

PMID:
21073441
17.

Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8. doi: 10.1097/QAI.0b013e31824206c7.

PMID:
22134144
18.

[Clinico-epidemiological characteristics of HIV-positive immigrants: study of 371 cases].

Llenas-García J, Rubio R, Hernando A, Fiorante S, Maseda D, Matarranz M, Costa JR, Alonso B, Pulido F.

Enferm Infecc Microbiol Clin. 2012 Oct;30(8):441-51. doi: 10.1016/j.eimc.2012.01.009. Spanish.

PMID:
22365618
19.

Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors.

Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):455-63. doi: 10.1097/QAI.0b013e3182a61e8d.

PMID:
23892242
20.

Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.

Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Ledergerber B; Swiss HIV Cohort Study..

HIV Med. 2009 Aug;10(7):407-16. doi: 10.1111/j.1468-1293.2009.00701.x.

Items per page

Supplemental Content

Support Center